La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Receptors, Dopamine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Cell Surface < Receptors, Dopamine < Receptors, Dopamine D1  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 34.
[20-40] [0 - 20][0 - 34]
Ident.Authors (with country if any)Title
001619 (1995) F. Thibaut ; B A Faucheux ; J. Marquez ; J. Villares ; J F Menard ; Y. Agid ; E C HirschRegional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine.
001703 (1993) E. Broussolle ; L. Cinotti ; P. Pollak ; P. Landais ; D. Le Bars ; G. Galy ; F. Lavenne ; Y. Khalfallah ; G. Chazot ; F. MauguièreRelief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease.
001705 (1993) J L Montastruc ; O. Rascol ; J M SenardCurrent status of dopamine agonists in Parkinson's disease management.
001728 (1993) P. Pollak ; A L Benabid ; P. Limousin ; C L Gervason ; E. Jeanneau-NicolleExternal and implanted pumps for apomorphine infusion in parkinsonism.
001736 (1993) Y. Agid ; M. Ruberg ; F. Javoy-Agid ; E. Hirsch ; R. Raisman-Vozari ; S. Vyas ; B. Faucheux ; P. Michel ; A. Kastner ; V. BlanchardAre dopaminergic neurons selectively vulnerable to Parkinson's disease?
001738 (1993) E C HirschDoes oxidative stress participate in nerve cell death in Parkinson's disease?
001760 (1992) F. Lisovoski ; C. Haby ; E. Borrelli ; C. Schleef ; M O Revel ; C. Hindelang ; J. ZwillerInduction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model.
001790 (1991) O. Rascol ; U. Sabatini ; M. Simonetta-Moreau ; J L Montastruc ; A. Rascol ; M. ClanetSquare wave jerks in parkinsonian syndromes.
001791 (????) J L MontastrucRecent advances in the clinical pharmacology of Parkinson's disease.
001826 (1990) Y. Agid ; A M Graybiel ; M. Ruberg ; E. Hirsch ; J. Blin ; B. Dubois ; F. Javoy-AgidThe efficacy of levodopa treatment declines in the course of Parkinson's disease: do nondopaminergic lesions play a role?
001830 (1990) F. Thibaut ; E C Hirsch ; R. Raisman ; F. Javoy-Agid ; Y. AgidMicrotopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.
001850 (1989) B. Pillon ; B. Dubois ; G. Cusimano ; A M Bonnet ; F. Lhermitte ; Y. AgidDoes cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?
001856 (1989) Y. Agid ; P. Cervera ; E. Hirsch ; F. Javoy-Agid ; S. Lehericy ; R. Raisman ; M. RubergBiochemistry of Parkinson's disease 28 years later: a critical review.
001860 (1988) L. Pierot ; C. Desnos ; J. Blin ; R. Raisman ; D. Scherman ; F. Javoy-Agid ; M. Ruberg ; Y. AgidD1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Receptors, Dopamine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Receptors, Dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Receptors, Dopamine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024